2021年美国癌症高剂量乳腺癌、宫颈癌和结直肠癌筛查试验使用情况。

IF 4.4 3区医学 Q1 PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH

Preventing Chronic Disease Pub Date : 2023-10-26 DOI:10.5888/pcd20.230071

Susan A Sabatino, Trevor D Thompson, Mary C White, Maria A Villarroel, Jean A Shapiro, Jennifer M Croswell, Lisa C Richardson

{"title":"2021年美国癌症高剂量乳腺癌、宫颈癌和结直肠癌筛查试验使用情况。","authors":"Susan A Sabatino, Trevor D Thompson, Mary C White, Maria A Villarroel, Jean A Shapiro, Jennifer M Croswell, Lisa C Richardson","doi":"10.5888/pcd20.230071","DOIUrl":null,"url":null,"abstract":"Introduction: We examined national estimates of breast, cervical, and colorectal cancer (CRC) screening test use and compared them with Healthy People 2030 national targets. Test use in 2021 was compared with prepandemic estimates.Methods: In 2022, we used 2021 National Health Interview Survey (NHIS) data to estimate proportions of adults up to date with US Preventive Services Task Force recommendations for breast (women aged 50-74 y), cervical (women aged 21-65 y), and CRC screening (adults aged 50-75 y) across sociodemographic and health care access variables. We compared age-standardized estimates from the 2021 and 2019 NHIS.Results: Percentages of adults up to date in 2021 were 75.7% (95% CI, 74.4%-76.9%), 75.2% (95% CI, 73.9%-76.4%), and 72.2% (95% CI, 71.2%-73.2%) for breast, cervical, and CRC screening, respectively. Estimates were below 50% among those without a wellness check in 3 years (all screening types), among those without a usual source of care or insurance (aged <65 y) (breast and CRC screening), and among those residing in the US for less than 10 years (CRC screening). Percentages of adults who were up to date with breast and cervical cancer screening and colonoscopy were similar in 2019 and 2021. Fecal occult blood/fecal immunochemical test (FOBT/FIT) use was modestly higher in 2021 (P < .001).Conclusions: In 2021, approximately 1 in 4 adults of screening age were not up to date with breast, cervical, and CRC screening recommendations, and Healthy People 2030 national targets were not met. Disparities existed across several characteristics, particularly those related to health care access. Breast, cervical, and colonoscopy test use within recommended screening intervals approximated prepandemic levels. FOBT/FIT estimates were modestly higher in 2021.","PeriodicalId":51273,"journal":{"name":"Preventing Chronic Disease","volume":null,"pages":null},"PeriodicalIF":4.4000,"publicationDate":"2023-10-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10625435/pdf/","citationCount":"0","resultStr":"{\"title\":\"Up-to-Date Breast, Cervical, and Colorectal Cancer Screening Test Use in the United States, 2021.\",\"authors\":\"Susan A Sabatino, Trevor D Thompson, Mary C White, Maria A Villarroel, Jean A Shapiro, Jennifer M Croswell, Lisa C Richardson\",\"doi\":\"10.5888/pcd20.230071\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Introduction: We examined national estimates of breast, cervical, and colorectal cancer (CRC) screening test use and compared them with Healthy People 2030 national targets. Test use in 2021 was compared with prepandemic estimates.Methods: In 2022, we used 2021 National Health Interview Survey (NHIS) data to estimate proportions of adults up to date with US Preventive Services Task Force recommendations for breast (women aged 50-74 y), cervical (women aged 21-65 y), and CRC screening (adults aged 50-75 y) across sociodemographic and health care access variables. We compared age-standardized estimates from the 2021 and 2019 NHIS.Results: Percentages of adults up to date in 2021 were 75.7% (95% CI, 74.4%-76.9%), 75.2% (95% CI, 73.9%-76.4%), and 72.2% (95% CI, 71.2%-73.2%) for breast, cervical, and CRC screening, respectively. Estimates were below 50% among those without a wellness check in 3 years (all screening types), among those without a usual source of care or insurance (aged <65 y) (breast and CRC screening), and among those residing in the US for less than 10 years (CRC screening). Percentages of adults who were up to date with breast and cervical cancer screening and colonoscopy were similar in 2019 and 2021. Fecal occult blood/fecal immunochemical test (FOBT/FIT) use was modestly higher in 2021 (P < .001).Conclusions: In 2021, approximately 1 in 4 adults of screening age were not up to date with breast, cervical, and CRC screening recommendations, and Healthy People 2030 national targets were not met. Disparities existed across several characteristics, particularly those related to health care access. Breast, cervical, and colonoscopy test use within recommended screening intervals approximated prepandemic levels. FOBT/FIT estimates were modestly higher in 2021.\",\"PeriodicalId\":51273,\"journal\":{\"name\":\"Preventing Chronic Disease\",\"volume\":null,\"pages\":null},\"PeriodicalIF\":4.4000,\"publicationDate\":\"2023-10-26\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10625435/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Preventing Chronic Disease\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.5888/pcd20.230071\",\"RegionNum\":3,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Preventing Chronic Disease","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.5888/pcd20.230071","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH","Score":null,"Total":0}

引用次数: 0

摘要

简介：我们研究了国家对癌症、宫颈癌和结直肠癌（CRC）筛查测试使用的估计，并将其与健康人2030年国家目标进行了比较。将2021年的测试使用情况与疫情前的估计进行了比较。方法：2022年，我们使用2021年全国健康访谈调查（NHIS）数据，根据美国预防服务工作组关于乳腺癌（50-74岁女性）、宫颈癌（21-65岁女性）和CRC筛查（50-75岁成年人）的最新建议，在社会人口统计和医疗保健可及变量中，估计成年人的比例。我们比较了2021年和2019年NHIS的年龄标准化估计值。结果：2021年迄今为止，乳腺、宫颈和CRC筛查的成年人百分比分别为75.7%（95%CI，74.4%-76.9%）、75.2%（95%CI、73.9%-76.4%）和72.2%（95%CI，71.2%-73.2%）。在3年内未进行健康检查的人群中（所有筛查类型），估计低于50%，那些没有通常护理或保险来源的人（老年人结论：2021年，大约四分之一的筛查年龄成年人没有达到乳腺、宫颈和结直肠癌筛查的最新建议，也没有达到2030年健康人的国家目标。几个特征之间存在差异，特别是与医疗保健相关的特征。在推荐的筛查间隔内使用乳腺、宫颈检查和结肠镜检查约ted大流行前的水平。2021年FOBT/FIT估计值略高。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

查看原文本刊更多论文

Up-to-Date Breast, Cervical, and Colorectal Cancer Screening Test Use in the United States, 2021.

Introduction: We examined national estimates of breast, cervical, and colorectal cancer (CRC) screening test use and compared them with Healthy People 2030 national targets. Test use in 2021 was compared with prepandemic estimates.

Methods: In 2022, we used 2021 National Health Interview Survey (NHIS) data to estimate proportions of adults up to date with US Preventive Services Task Force recommendations for breast (women aged 50-74 y), cervical (women aged 21-65 y), and CRC screening (adults aged 50-75 y) across sociodemographic and health care access variables. We compared age-standardized estimates from the 2021 and 2019 NHIS.

Results: Percentages of adults up to date in 2021 were 75.7% (95% CI, 74.4%-76.9%), 75.2% (95% CI, 73.9%-76.4%), and 72.2% (95% CI, 71.2%-73.2%) for breast, cervical, and CRC screening, respectively. Estimates were below 50% among those without a wellness check in 3 years (all screening types), among those without a usual source of care or insurance (aged <65 y) (breast and CRC screening), and among those residing in the US for less than 10 years (CRC screening). Percentages of adults who were up to date with breast and cervical cancer screening and colonoscopy were similar in 2019 and 2021. Fecal occult blood/fecal immunochemical test (FOBT/FIT) use was modestly higher in 2021 (P < .001).

Conclusions: In 2021, approximately 1 in 4 adults of screening age were not up to date with breast, cervical, and CRC screening recommendations, and Healthy People 2030 national targets were not met. Disparities existed across several characteristics, particularly those related to health care access. Breast, cervical, and colonoscopy test use within recommended screening intervals approximated prepandemic levels. FOBT/FIT estimates were modestly higher in 2021.

求助全文

通过发布文献求助，成功后即可免费获取论文全文。去求助

来源期刊

Preventing Chronic Disease PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH-

CiteScore

6.70

自引率

3.60%

发文量

期刊介绍： Preventing Chronic Disease (PCD) is a peer-reviewed electronic journal established by the National Center for Chronic Disease Prevention and Health Promotion. The mission of PCD is to promote the open exchange of information and knowledge among researchers, practitioners, policy makers, and others who strive to improve the health of the public through chronic disease prevention. The vision of PCD is to be the premier forum where practitioners and policy makers inform research and researchers help practitioners and policy makers more effectively improve the health of the population. Articles focus on preventing and controlling chronic diseases and conditions, promoting health, and examining the biological, behavioral, physical, and social determinants of health and their impact on quality of life, morbidity, and mortality across the life span.